Trading news

Biotech Stocks Surged: Moderna, BioNTech, Novavax

The biotech industry has always had a high potential to grow, but the pandemic has boosted this sector even more and as a result, attracted many new investors especially vaccine producers. Let’s go through the top stocks of the biotech industry.

Moderna

Moderna surged on the announcement that its Covid-19 vaccine was granted provisional registration by Australia's administration. Moderna is planning to supply as many as 25 million doses of its vaccine to the Australian government by 2022.

However, this company has a unique feature. It has joined one of the most credible stock indexes in the US – the S&P 500 index. It helped the stock to rise even more! Check our recent article to see what happened with Tesla when it joined S&P 500.

Moderna has almost reached the psychological mark of $500.00, but as it often happens, it has failed to cross such an important level on the first try. We can expect that sooner or later, it will break this resistance level and rally up further to the next round number of $550.00. Support levels are $400 and $350.00.

1

Pfizer and BioNTech

BioNTech and Pfizer have recently published better than expected earnings results for the second quarter. The companies claimed they can produce up to 3 billion Covid-19 vaccines this year, with capacity increasing to 4 billion doses in 2022. Pfizer is getting closer to the $50.00 level, while BioNTech has reversed down from $463.00.

2

 

3

Novavax

Meanwhile, Novavax has gained from Barron’s article. It was written that the New York State Common Retirement Fund, the third-largest public pension in the US, has increased its stake in Novavax and other vaccine stocks. However, the vaccine maker claimed that it would delay submission of its Covid-19 vaccine to the Food and Drug Administration for emergency use authorization until the fourth quarter.

The breakout above the $240.00 resistance level will push the stock up to the high of April 27 at $260.00. After that, the stock price may jump to an all-time high near $320.00. Support levels are the 100- and 200-day moving averages of $190.00 and $170.00, respectively.   

4

If you want to trade stocks with FBS, download FBS Trader app or Metatrader 5

 

Disclaimer

This post is written and submitted by FBS Markets for informational purposes only. In no way shall it be interpreted or construed to create any warranties of any kind, including an offer to buy or sell any currencies or other instruments. 

The views and ideas shared in this article are deemed reliable and based on the most up-to-date and trustworthy sources. However, the company does not take any responsibility for accuracy and completeness of the information, and the views expressed in the article may be subject to change without prior notice. 

FBS Review

Wednesday, 11 Aug, 2021 / 9:48

Note: Company News is a promotional service of the Directory and the content isn't created by Finance Magnates.

Source : https://fbs.com/analytics/articles/biotech-stocks-surged-moderna-biontech-novavax-32356

Trading news

 

Evergrande jitters return, yen climbs, dollar steady

  Evergrande shares plunge after sale of unit falls through, mood [...]

Posted on Thursday, 21 Oct, 2021 / 10:24 under

October’s Global Flash PMIs: FX Volatility Day

Given the situation in global supply chains, PMI data has returned to focus. [...]

Posted on Thursday, 21 Oct, 2021 / 10:22 under

Oil: The Perfect Storm Keeps Brewing

Last night, workers at a US refinery in Texas voted against resuming work in [...]

Posted on Wednesday, 20 Oct, 2021 / 10:27 under